Tharimmune Faces Delisting Concerns
Ticker: CNTN · Form: 8-K · Filed: Apr 4, 2025 · CIK: 1861657
| Field | Detail |
|---|---|
| Company | Tharimmune, INC. (CNTN) |
| Form Type | 8-K |
| Filed Date | Apr 4, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory-filing
TL;DR
THARIMUNE IS ON THE EDGE OF BEING DELISTED - MAJOR RED FLAG!
AI Summary
Tharimmune, Inc. filed an 8-K on April 1, 2025, to report a notice of delisting or failure to satisfy a continued listing rule. The company, formerly known as Hillstream BioPharma Inc., is incorporated in Delaware and has its principal executive offices in Bridgewater, NJ.
Why It Matters
This filing indicates potential issues with Tharimmune's continued listing on an exchange, which could significantly impact its stock value and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's stock trading status and overall financial health.
Key Numbers
- 001-41210 — Commission File Number (Identifies the company's filing with the SEC)
- 84-2642541 — I. R. S. Employer Identification No. (Company's tax identification number)
Key Players & Entities
- Tharimmune, Inc. (company) — Registrant
- April 1, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Bridgewater, NJ (location) — Address of principal executive offices
- Hillstream BioPharma Inc. (company) — Former company name
FAQ
What specific listing rule or standard has Tharimmune, Inc. failed to satisfy?
The filing does not specify the exact rule or standard that Tharimmune, Inc. has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule has been issued.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is April 1, 2025.
What was Tharimmune, Inc.'s former company name?
Tharimmune, Inc.'s former company name was Hillstream BioPharma Inc.
In which state is Tharimmune, Inc. incorporated?
Tharimmune, Inc. is incorporated in Delaware.
What is the address of Tharimmune, Inc.'s principal executive offices?
The address of Tharimmune, Inc.'s principal executive offices is 1200 Route 22 East, Suite 2000, Bridgewater, NJ 08807.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 4, 2025 regarding Tharimmune, Inc. (CNTN).